FRANCISCO
ALÉN FARIÑAS
Profesor contratado doctor
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (8)
2021
-
Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108
2019
-
Oleoylethanolamide, neuroinflammation, and alcohol abuse
Frontiers in Molecular Neuroscience, Vol. 11
-
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Neuropharmacology, Vol. 149, pp. 212-220
2018
-
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women
Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250
2016
2013
-
Cannabinoid Receptors and Cholecystokinin in Feeding Inhibition
Vitamins and Hormones (Academic Press Inc.), pp. 165-196
-
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism
PLoS ONE, Vol. 8, Núm. 4
2012
-
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration
Pharmacology Biochemistry and Behavior, Vol. 101, Núm. 1, pp. 1-7